Topical corticosteroids, once revolutionary for treatment of atopic dermatitis, are used just sparingly today; dermatologist Mona Shahriari, MD, lists the reasons.
Topical corticosteroids? "We thought they were the best things since sliced bread," Mona Shahriari, MD, joked during an interview with Patient Care.® That was in the 1950s when the agents really were a revolutionary addition to the dermatology toolbox for treating atopic dermatitis, she added. But over time the limitations to the use of topical steroids became very clear. In this short video, Shahriari highlights the drawbacks that are well recognized today.
For Shahriari's follow-up discussion of the nonsteroidal topical treatments available now for atopic dermatitis, click here.
Mona Shahriari, MD, is assistant clinical professor of dermatology at Yale University School of Medicine in New Haven, Connecticut and co-founder of Central Connecticut Dermatology in Cromwell, Connecticut.
Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care
September 24th 2025Patient Care tapped the rich trove of research and expert perspectives from the Revolutionizing Atopic Dermatitis 2025 conference to create a snapshot of the AD care of the future.